The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents

Author(s): S. G. Buchanan, J. M. Sauder, T. Harris.

Journal Name: Current Pharmaceutical Design

Volume 8 , Issue 13 , 2002


Structural Genomics stands out among the emerging fields of proteomics since it influences the drug discovery process at so many points. Recent developments in protein expression technologies, x-ray crystallography and NMR spectroscopy provide the essential elements for high-throughput structure determination platforms. Bioinformatics methods to interrogate the resulting data will provide comprehensive, genome-wide databases of protein structure. Genomic sequencing and methods for high-throughput expression and protein purification are furthest advanced for microbial genes and so these have been the early targets for structural genomics initiatives. The information will be invaluable in understanding gene function, designing broad-spectrum small molecule inhibitors and in better understanding drug-host interactions.

Keywords: structural genomics, antimicrobial agents, proteomics

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2002
Page: [1173 - 1188]
Pages: 16
DOI: 10.2174/1381612023394809
Price: $65

Article Metrics

PDF: 1